Press Releases

The following are official statements issued by UsAgainstAlzheimer’s in response to major national policy actions, industry events, breaking news, or organizational achievements. Please see the UsAgainstAlzheimer’s press kit page for additional information. For media requests, please contact Jon Summers at [email protected].

  • June 10, 2024

    FDA Advisory Committee Unanimously Endorses Donanemab for Full Approval

    An advisory committee convened by the Food and Drug Administration (FDA) to...

    Read more
  • June 07, 2024

    UsAgainstAlzheimer’s Statement on New Study Showing Lifestyle Changes Reverse Alzheimer’s Symptoms

    Washington, DC (June 7, 2024) — A newly-released study published in Alzheimer’s...

    Read more
  • May 15, 2024

    FDA Decision to Fast Track Consideration of Subcutaneous Leqembi is Good News for Alzheimer’s Patients

    Washington, DC (May 14, 2024) — Eisai and Biogen, the developers of...

    Read more
  • April 16, 2024

    UsAgainstAlzheimer’s Launches 2024 Brain Health Academy

    Six new monthly sessions added to the free continuing education program for...

    Read more
  • April 16, 2024

    UsAgainstAlzheimer’s Appoints Vivian Vasallo as Vice President for Early Detection

    UsAgainstAlzheimer’s Appoints Vivian Vasallo as Vice President for Early Detection

    Read more
  • April 10, 2024

    UsAgainstAlzheimer’s Statement on Selection of Rep. Tom Cole's as Next House Appropriations Chair

    UsAgainstAlzheimer’s released the following statement in response to the appointment of U.S...

    Read more
  • March 25, 2024

    Congress Passes Bill Making Major Investments in Alzheimer’s

    Bill Increases Funding for Alzheimer’s Research and Prevention Efforts

    Read more
  • March 20, 2024

    Important Alzheimer’s Bills Advance in Congress

    Read more
  • March 08, 2024

    FDA Delays Approval of Donanemab for the Treatment of Early-Stage Alzheimer’s

    Agency to convene an advisory committee to consider the drug.

     

    Read more

Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s

The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer's. This report found that deep social inequities exist in countries highly impacted by Alzheimer's among Latinos and Blacks.